Valeant Pharmaceuticals

And that form is a lawsuit which he has to pay lawyers to file. Phone calls, e-mails, letters, telegrams, CNBC appearances, PowerPoint presentations and carrier pigeons with the query, “Will my plan to solicit proxies to oust a majority of your stupid, intransigent board cause me troubles vis-à-vis poison pills?” were allegedly and will be in the future ignored, returned unread or turned over to Allergan’s vaunted R&D operations. Read more »

Valeant Pharmaceuticals CEO Michael Pearson hasn’t quite gotten a quarter of Allergan’s shares pledged to having a special vote on his $53 billion offer for the company, but that isn’t shaking his confidence. Read more »

Allergan, which Bill Ackman would very much like to see become a subsidiary of Valeant Pharmaceutricals, is based in Irvine, Calif. Ed Royce is a congressman who represents a swath of Orange County to Irvine’s north, and who presumably counts a few Allergan employees as constituents, and who will be spending some of Allergan’s money in an effort to be reelected in November.

This same Ed Royce does not think much of Bill Ackman’s plan to take it to the people and ask Allergan shareholders whether they’d like to take the now $49.9 billion Valeant would like to give them for their company, and he’s not afraid to tell Mary Jo White all about it. Read more »

It’s got, like, other options. And it so did not get rejected by the cooler pharmas. Just cool it and let it figure things out. Jeez. Read more »

Nobody asked Bill Ackman if he was OK with Allergan telling Valeant to go shove it because they’re a terrible company whose only business is to buy other businesses. He’d like to know if they asked anybody else. Read more »

Bill Ackman’s Boyish Visage To Be Preserved For Posterity

The Pershing Square Capital Management chief will never have to grow a beard to hide his frown lines if he can pull off his latest effort. Read more »